Greg Lan
Non-Executive Director / Probiotec
Greg Lan was the founding managing director of Aspen Pharmacare Australia, a subsidiary of South African listed Aspen Pharmacare Holdings. During his tenure, Aspen Australia experienced growth, after the acquisition of Sigma's branded and generics portfolio in 2011 as well as its manufacturing facilities.
Prior to joining Aspen, Mr Lan has had experience working in the pharmaceutical industry internationally, including senior roles with Ciba-Geigy (now Novartis) in Switzerland and Saudi Arabia, as well as with Sanofi Aventis in Australia.
